HIV screening for all: The new standard of care

Cleveland Clinic Journal of Medicine

Volumn 74, Issue 4, 2007, Pages 297-301

  Armstrong, Wendy S ^a   Taege, Alan J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247111489     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.4.297     Document Type: Article

References (13)

1. Branson BM, Handsfield HH, Lampe MA, et al; Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55(RR-14):1-17.
2. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with virus in the USA. AIDS 2006; 20:1447-1450.
3. Centers for Disease Control and Prevention (CDC). Trends in HIV/ AIDS diagnoses - 33 states, 2001-2004. MMWR Morb Mortal Wkly Rep 2005, 54(45):1149-1153.
4. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2004. Vol. 16. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2005. www.cdc.gov/hiv/stats/hasrlink.htm. Accessed 3/12/2007.
5. Simpson WM, Johnstone FD, Goldberg DJ, Gormley SM, Hart GJ. Antenatal HIV testing: assessment of a routine voluntary approach. BMJ 1999; 318:1660-1661.
6. US Preventive Services Task Force. Methodology. In: Guide to Clinical Preventive Services, 2nd ed. Report of the U.S. Preventive Services Task Force. Baltimore: Williams and Wilkins, 1995:xxxix-lv. adphp.osophs.dhhs.gov/pubs/guidecps/PDF/Frontmtr:PDF. Accessed 3/12/2007.
7. Mylonakis E, Paliou M, Lally M, Flanigan TP, Rich JD. Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. Am J Med 2000; 109:568-576.
8. Walensky RP, Paltiel AD, Losina E, at al. The survival benefits of AIDS treatment in the United States. J Infect Dis 2006; 194:11-19.
9. Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 2005, 352:570-585.
10. Bozzette SA. Routine screening for HIV infection - timely and cost-effective. N Engl J Med 2005; 352:620-621.
11. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N Engl J Med 2005; 352:586-595.
12. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39:446-453.
13. Public Health Service Task Force. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. October 12, 2006. www.aldsinfo.nih.gov/ContentFiles/ PerinaIGL.pdf. Accessed 3/12/2007